Exhibiting at VIV Asia 2025

Zhejiang Share Bio-Pharm Co., Ltd., headquartered in Hangzhou, China, is a leading manufacturer and global supplier of veterinary pharmaceutical ingredients, feed-grade premixes, and food additives. With decades of experience in pharmaceutical chemistry and large-scale GMP-compliant production, the company plays a critical role in supplying high-purity APIs and additives to international animal health and food industries.

Core Business and Offerings

Zhejiang Share Bio-Pharm specializes in:

• Active Pharmaceutical Ingredients (APIs)

  • Amprolium Hydrochloride
  • Ceftiofur Hydrochloride
  • Ceftiofur Sodium
  • Cefquinome Sulfate
  • Fosfomycin Sodium and Calcium
  • Amoxicillin Trihydrate
  • Enramycin 4% and 8%

• Premixes

  • Enramycin 4% and 8%
  • Colistin Sulfate 10%
  • Avilamycin 10% and 20%

• Food Additives

  • Potassium Carbonate
  • Potassium Bicarbonate
  • Potassium Chloride
  • Ammonium Chloride

• Pharmaceutical Intermediates

  • 2-Chloro-6-Fluorobenzaldehyde
  • 2-Chloro-6-Fluorobenzyl Chloride

These products serve a diverse clientele including feed mills, veterinary drug formulators, premix manufacturers, and food ingredient distributors across the globe.

Specialisation and Core USP

Zhejiang Share Bio-Pharm is recognized for its:

• High-purity API production using advanced synthesis technologies
• Integrated supply chain control with multi-site production facilities
• Expertise in fermentation-based antibiotic production (notably Enramycin)
• Fully equipped QA/QC laboratories with HPLC, GC, UV, and IR spectrometers
• Batch-to-batch consistency and traceability assurance

The company’s regulatory strength and technical documentation capabilities enable fast market access in regulated regions.

Global Market Presence

Zhejiang Share Bio-Pharm exports to over 50 countries, with key markets in:

• Asia: Vietnam, India, Indonesia, Thailand
• Europe: Russia, Poland, Spain
• Latin America: Brazil, Mexico, Colombia
• Middle East and Africa: Egypt, Iran, South Africa

It has developed long-term partnerships with global veterinary drug formulators and feed manufacturers, and has a growing presence in regulated markets through DMF submissions and CEP filings.

Shipment and Trade Data

Based on shipment intelligence from platforms like ImportYeti and Volza:

• The company has conducted over 200 international container shipments from 2021 to 2024
• Annual export value is estimated at USD 8–10 million
• Top-shipped products include Enramycin premix, Amprolium HCl, and Fosfomycin Sodium
• Regular customers include distributors in Vietnam, Brazil, and the Middle East

Capabilities

The company operates multiple GMP-certified production lines and provides:

• Custom synthesis services for intermediates and APIs
• Stability studies, technical dossiers, and regulatory registration support
• Bulk and small-lot shipment capabilities
• OEM and contract manufacturing for veterinary formulations

Zhejiang Share Bio-Pharm also maintains dedicated regulatory affairs and export documentation teams to support swift product clearance and import authorization.

Certifications and Compliance

Zhejiang Share Bio-Pharm’s facilities and processes are aligned with:

• GMP (Good Manufacturing Practice) for veterinary APIs and premixes
• ISO 9001:2015 Quality Management System
• FAMI-QS and HACCP standards for feed-grade production
• DMF registration in multiple countries
• WHO guidelines for active ingredient traceability and environmental compliance

The company’s stringent QC protocols cover in-process checks, finished product release testing, and retention sample monitoring.

Major Achievements

• Recognized as a Top 10 Veterinary API Exporter from Zhejiang province
• Successfully registered Enramycin and Fosfomycin in multiple Southeast Asian and Latin American markets
• Annual capacity of 500+ tons of feed-grade APIs and premixes
• Developed long-term CMO partnerships with major EU and Latin American veterinary brands

Zhejiang Share Bio-Pharm Co., Ltd. continues to solidify its role as a reliable and technically advanced supplier in the global veterinary pharmaceutical supply chain, backed by regulatory excellence, production strength, and deep industry experience.